superduperinvst

@superduperinvst

This creator specialises in unearthing deeply undervalued small-cap and micro-cap stocks — particularly in biotech and emerging tech — before institutional money arrives, aiming to get followers in at ground-floor prices ahead of major catalysts like FDA decisions or buyout events. Known for coining the term 'PAYtience,' they advocate a disciplined buy-on-dips, hold-for-the-catalyst approach that has produced several high-profile multi-hundred-percent wins. They also flag overvalued momentum names as short candidates, providing a contrarian perspective across both sides of the market.